ID | 48853 |
フルテキストURL | |
著者 |
Kojima, Toru
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hashimoto, Yuuri
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Watanabe, Yuichi
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kagawa, Shunsuke
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
Uno, Futoshi
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
Kuroda, Shinji
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tazawa, Hiroshi
Center for Gene and Cell Therapy, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
Kyo, Satoru
Department of Obstetrics and Gynecology, Kanazawa University School of Medicine
Mizuguchi, Hiroyuki
Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University
Urata, Yasuo
Oncolys BioPharma Inc.
Tanaka, Noriaki
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Toshiyoshi
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
|
抄録 | The presence of circulating tumor cells (CTCs) in the peripheral blood is associated with short survival, making the detection of CTCs clinically useful as a prognostic factor of disease outcome and/or a surrogate marker of treatment response. Recent technical advances in immunocytometric analysis and quantitative real-time PCR have made it possible to detect a few CTCs in the blood; however, there is no sensitive assay to specifically detect viable CTCs. Here, we report what we believe to be a new approach to visually detect live human CTCs among millions of peripheral blood leukocytes, using a telomerase-specific replication-selective adenovirus expressing GFP. First, we constructed a GFP-expressing attenuated adenovirus, in which the telomerase promoter regulates viral replication (OBP-401; TelomeScan). We then used OBP-401 to establish a simple ex vivo method that was able to detect viable human CTCs in the peripheral blood. The detection method involved a 3-step procedure, including the lysis of rbc, the subsequent addition of OBP-401 to the cell pellets, and an automated scan using fluorescence microscopy. OBP-401 infection increased the signal-to-background ratio as a tumor-specific probe, because the fluorescent signal was amplified only in viable, infected human tumor cells, by viral replication. This GFP-expressing virus-based method is remarkably simple and allows precise enumeration of CTCs.
|
発行日 | 2009-10-01
|
出版物タイトル |
The Journal of Clinical Investigation
|
巻 | 119巻
|
号 | 10号
|
出版者 | American Society for Clinical Investigation
|
開始ページ | 3172
|
終了ページ | 3181
|
ISSN | 0021-9738
|
NCID | AA00695520
|
資料タイプ |
学術雑誌論文
|
プロジェクト |
ナノバイオ標的医療の融合的創出拠点
|
オフィシャル URL | http://www.jci.org/articles/view/38609
|
言語 |
英語
|
著作権者 | © 2009, American Society for Clinical Investigation
|
論文のバージョン | publisher
|
査読 |
有り
|
DOI | |
PubMed ID | |
Web of Science KeyUT |